1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Baricitinib
Trade Name:
Olumiant
Manufacturer/Distributor:
Eli Lilly Canada
Classification:
Immunosuppressant
ATC Class:
L04AA37 - baricitinib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/08/17
Date Marketed in Canada (yyyy/mm/dd):
2018/08/17
Presentation:
Tablet: 2 mg (oral disintegrating tablet). DIN: 02480018
Comments:
For use, in combination with methotrexate, for reducing the signs and symptoms of moderate to severe rheumatoid arthritis in adult patients who have responded inadequately to one or more disease-modifying anti-rheumatic drugs. It may be used as monotherapy in cases of intolerance to methotrexate.
Source:
Product monograph
Back to:
Drug Product Listings 
